Network-1 Technologies, Inc.

Financials

v3.25.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2025
Dec. 31, 2024
CURRENT ASSETS:    
Cash and cash equivalents $ 7,708,000 $ 13,145,000
Marketable securities, at fair value 29,389,000 27,455,000
Other current assets 166,000 232,000
  TOTAL CURRENT ASSETS 37,263,000 40,832,000
  OTHER ASSETS:    
Patents, net of accumulated amortization 1,516,000 1,205,000
Equity investment 2,242,000 3,337,000
Operating leases right-of-use asset 27,000
Security deposit 13,000 13,000
  Total Other Assets 3,771,000 4,582,000
  TOTAL ASSETS 41,034,000 45,414,000
CURRENT LIABILITIES:    
Accounts payable 220,000 203,000
Accrued payroll 292,000
Other accrued expenses 187,000 247,000
Operating lease obligations 24,000
  Total Current Liabilities 407,000 766,000
  LONG TERM LIABILITIES:      
       Deferred tax liability 105,000 337,000
  TOTAL LIABILITIES 512,000 1,103,000
  COMMITMENTS AND CONTINGENCIES (Note G)  
  STOCKHOLDERS’ EQUITY    
Preferred stock, $0.01 par value, authorized 10,000,000 shares; none issued and outstanding at September 30, 2025 and December 31, 2024
Common stock, $0.01 par value; authorized 50,000,000 shares; 22,820,593 and 22,961,619 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 228,000 229,000
Additional paid-in capital 63,346,000 65,455,000
Accumulated deficit (23,052,000) (21,373,000)
TOTAL STOCKHOLDERS’ EQUITY 40,522,000 44,311,000
  TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 41,034,000 $ 45,414,000

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL
v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
REVENUE $ 150,000 $ 100,000
OPERATING EXPENSES:        
Costs of revenue 42,000 28,000
Professional fees and related costs 226,000 290,000 511,000 656,000
General and administrative 537,000 576,000 1,658,000 1,764,000
Amortization of patents 37,000 30,000 104,000 90,000
TOTAL OPERATING EXPENSES 800,000 896,000 2,315,000 2,538,000
OPERATING LOSS (800,000) (896,000) (2,165,000) (2,438,000)
  OTHER INCOME:        
Interest and dividend income, net 467,000 524,000 1,396,000 1,407,000
Net realized and unrealized gain on marketable securities 44,000 293,000 215,000 395,000
Total other income, net 511,000 817,000 1,611,000 1,802,000
  LOSS BEFORE INCOME TAXES AND SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE (289,000) (79,000) (554,000) (636,000)
INCOME TAXES PROVISION:        
Current (31,000)
Deferred taxes, net (83,000) (71,000) (232,000) (355,000)
Total income tax benefit (83,000) (71,000) (263,000) (355,000)
LOSS BEFORE SHARE OF NET LOSS OF EQUITY METHOD INVESTEE: (206,000) (8,000) (291,000) (281,000)
SHARE OF NET LOSS OF EQUITY METHOD INVESTEE (354,000) (308,000) (1,095,000) (1,613,000)
  NET LOSS $ (560,000) $ (316,000) $ (1,386,000) $ (1,894,000)
Net loss per share        
Basic $ (0.02) $ (0.01) $ (0.06) $ (0.08)
Diluted $ (0.02) $ (0.01) $ (0.06) $ (0.08)
Weighted average common shares outstanding:        
Basic 22,807,916 23,126,480 22,858,180 23,337,716
Diluted 22,807,916 23,126,480 22,858,180 23,337,716
Cash dividends declared per share $ 0.05 $ 0.05 $ 0.10 $ 0.10

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL
v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
  Net loss $ (1,386,000) $ (1,894,000)
  Adjustments to reconcile net loss to net cash used in operating activities    
Amortization of patents 104,000 90,000
Stock-based compensation 227,000 313,000
Loss allocated from equity method investment 1,095,000 1,613,000
Unrealized gain on marketable securities (108,000) (244,000)
Deferred tax benefit (232,000) (355,000)
Amortization of operating leases – right of use assets 27,000 48,000
Changes in operating assets and liabilities:    
Other current assets 66,000 65,000
Accounts payable 17,000 246,000
Operating lease obligations (24,000) (58,000)
Accrued expenses (392,000) (509,000)
  NET CASH USED IN OPERATING ACTIVITIES (606,000) (685,000)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Sales of marketable securities 10,192,000 13,582,000
Purchases of marketable securities (12,018,000) (11,968,000)
Acquisition of patents (415,000)
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES (2,241,000) 1,614,000
  CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends paid (2,296,000) (2,366,000)
Value of shares delivered to fund payment of withholding taxes (7,000) (61,000)
Repurchases of common stock, inclusive of commissions and excise tax (287,000) (1,083,000)
NET CASH USED IN FINANCING ACTIVITIES: (2,590,000) (3,510,000)
NET DECREASE IN CASH AND CASH EQUIVALENTS (5,437,000) (2,581,000)
CASH AND CASH EQUIVALENTS, beginning of period 13,145,000 16,896,000
CASH AND CASH EQUIVALENTS, end of period 7,708,000 14,315,000
Cash paid during the period for:    
  Interest
  Income taxes
NON-CASH FINANCING ACTIVITIES    
Accrued dividend rights on restricted stock units 51,000 59,000
Right of use asset for lease liability $ 75,000

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL